Blog
RSS FeedPosted by Michael Wonder on 09 May 2026
Vertex announces Casgevy reimbursement agreement for the treatment of sickle cell disease and transfusion-dependent beta thalassaemia in Germany
6 May 2026 - The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and ...
Posted by Michael Wonder on 30 Nov 2017
New report reveals need for a gender-based approach to health funding for women to have full economic empowerment
30 November 2017 - Recent CADTH recommendation to improve access to oral uterine fibroids treatment presents positive step forward in helping ...